Positive response to 'gift tokens for undetectable viral load' trial
Restoring and maintaining a high CD4 count possible for vast majority of people living with HIV in France
What are the barriers that could stop HIV treatment becoming HIV prevention?
Once-daily dolutegravir superior to darunavir/ritonavir in 96-week follow-up
Doravirine works as well as efavirenz with fewer CNS side-effects
Protease inhibitor monotherapy: darunavir/ritonavir less effective than three-drug therapy
Efavirenz compromises hormonal contraceptive implant
Do emtricitabine and lamivudine have similar virological efficacy when used in first-line HIV therapy?
